triciribine phosphate has been researched along with Anaplastic Astrocytoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amlin-Van Schaick, JC; Anastassiadis, T; Connell-Albert, YS; Gürsel, DB; Hawes, JJ; Reilly, KM; Tuskan, RG; Walrath, JC | 1 |
1 other study(ies) available for triciribine phosphate and Anaplastic Astrocytoma
| Article | Year |
|---|---|
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies.
Topics: Acenaphthenes; Animals; Astrocytoma; Blotting, Western; Brain Neoplasms; Cell Adhesion; Cell Movement; Cell Proliferation; ErbB Receptors; Female; Furans; Genes, Neurofibromatosis 1; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase Kinases; Molecular Targeted Therapy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyridines; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Ribonucleotides; Signal Transduction; Tumor Cells, Cultured | 2011 |